2023-08-01 2024-07-31 false Capium Accounts Production 1.1 12527794 2023-08-01 2024-07-31 12527794 bus:AbridgedAccounts 2023-08-01 2024-07-31 12527794 bus:FRS102 2023-08-01 2024-07-31 12527794 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 12527794 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 12527794 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 12527794 2023-08-01 2024-07-31 12527794 2024-07-31 12527794 bus:RegisteredOffice 2023-08-01 2024-07-31 12527794 core:WithinOneYear 2024-07-31 12527794 core:AfterOneYear 2024-07-31 12527794 1 2023-08-01 2024-07-31 12527794 bus:Director1 2023-08-01 2024-07-31 12527794 bus:Director1 2024-07-31 12527794 bus:Director1 2022-08-01 2023-07-31 12527794 2022-08-01 12527794 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 12527794 2022-08-01 2023-07-31 12527794 2023-07-31 12527794 core:WithinOneYear 2023-07-31 12527794 core:AfterOneYear 2023-07-31 12527794 bus:EntityAccountantsOrAuditors 2022-08-01 2023-07-31 12527794 bus:OrdinaryShareClass1 2023-08-01 2024-07-31 12527794 bus:OrdinaryShareClass1 2024-07-31 12527794 bus:OrdinaryShareClass1 2022-08-01 2023-07-31 12527794 bus:OrdinaryShareClass1 2023-07-31 12527794 core:FurnitureFittings 2023-08-01 2024-07-31 12527794 core:FurnitureFittings 2024-07-31 12527794 core:FurnitureFittings 2023-07-31 12527794 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 12527794 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-07-31 12527794 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 12527794 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 12527794 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-07-31 12527794 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 12527794 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 12527794 core:Non-currentFinancialInstruments 2024-07-31 12527794 core:Non-currentFinancialInstruments 2023-07-31 12527794 core:ShareCapital 2024-07-31 12527794 core:ShareCapital 2023-07-31 12527794 core:RetainedEarningsAccumulatedLosses 2024-07-31 12527794 core:RetainedEarningsAccumulatedLosses 2023-07-31 12527794 dpl:Item1 2023-08-01 12527794 dpl:Item1 2024-07-31 12527794 dpl:Item1 2022-08-01 12527794 dpl:Item1 2023-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12527794
England and Wales

 

 

 

JYS HEALTH LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 August 2023

End date: 31 July 2024
Report to the directors on the preparation of the unaudited statutory accounts of JYS HEALTH LIMITED for the year ended 31 July 2024.
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of JYS HEALTH LIMITED for the year ended 31 July 2024 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/.
This report is made solely to the Board of Directors of JYS HEALTH LIMITED, as a body, in accordance with the terms of our engagement letter dated 09 December 2023. Our work has been undertaken solely to prepare for your approval the accounts of JYS HEALTH LIMITED and state those matters that we have agreed to state to the Board of Directors of JYS HEALTH LIMITED, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than JYS HEALTH LIMITED and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that JYS HEALTH LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of JYS HEALTH LIMITED. You consider that JYS HEALTH LIMITED is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of JYS HEALTH LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
31 July 2024.



....................................................
RAGAVAN AND CO LTD
CHARTERED CERTIFIED ACCOUNTANTS
240 GROVE LANE
BIRMINGHAM
WEST MIDLANDS
B20 2EY
15 April 2025
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 2,991    1,442 
2,991    1,442 
Current assets      
Cash at bank and in hand 37,487    21,257 
Creditors: amount falling due within one year (15,290)   (8,945)
Net current assets 22,197    12,312 
 
Total assets less current liabilities 25,188    13,754 
Net assets 25,188    13,754 
 

Capital and reserves
     
Called up share capital 4 5    5 
Profit and loss account 25,183    13,749 
Shareholders' funds 25,188    13,754 
 


For the year ended 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 15 April 2025 and were signed by:


-------------------------------
TAMBIMUTTU Neel Gnana
Director
2
General Information
JYS HEALTH LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12527794, registration address 240 GROVE LANE, HANDSWORTH, BIRMINGHAM, WEST MIDLANDS, B20 2EY.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 20% Reducing Balance
2.

Average number of employees

There was none in this year.
Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 01 August 2023 2,591    2,591 
Additions 1,874    1,874 
Disposals  
At 31 July 2024 4,465    4,465 
Depreciation
At 01 August 2023 1,149    1,149 
Charge for year 325    325 
On disposals  
At 31 July 2024 1,474    1,474 
Net book values
Closing balance as at 31 July 2024 2,991    2,991 
Opening balance as at 01 August 2023 1,442    1,442 


4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
5 Class A shares of £1.00 each  
 

3